Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02622893Phase 4Completed
Phase 4, single-blind trial (2 arms), sponsored by Istanbul University. Primary endpoint: Total epidural analgesic consumption at 24 hours. Started Jan 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02622893.